Cytosorbents Corp (NASDAQ:CTSO)

10.55
Delayed Data
As of May 18
 +0.50 / +4.98%
Today’s Change
3.30
Today|||52-Week Range
10.90
+62.31%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close10.05
Today’s open10.10
Day’s range9.95 - 10.90
Volume587,248
Average volume (3 months)205,081
Market cap$252.3M
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+31.91%
Earnings growth (this year)-42.19%
Earnings growth (next 5 years)--
Revenue growth (last year)+59.02%
P/E ratioNM
Price/Sales11.85
Price/Book23.71

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp+0.16+4.30%
NVLNNovelion Therapeutic...-0.04-0.89%
CDTXCidara Therapeutics ...-0.05-1.05%
NATRNatures Sunshine Pro...+0.05+0.53%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$15.2M
Annual profit (last year)-$8.5M
Net profit margin-55.84%

Profile

Sector
Health Technology
Industry
Medical Specialties
President Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent J. Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts